Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) Shares Outstanding (Diluted Average) (2022 - 2025)

United Health Products (UEEC) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $256.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 3.13% to $256.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $256.4 million, a 3.13% increase, with the full-year FY2024 number at $248.2 million, up 3.8% from a year prior.
  • Shares Outstanding (Diluted Average) was $256.4 million for Q3 2025 at United Health Products, roughly flat from $257.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $279.7 million in Q3 2022 to a low of $233.3 million in Q1 2023.
  • A 4-year average of $248.9 million and a median of $247.9 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 13.65% in 2023, then grew 5.34% in 2024.
  • United Health Products' Shares Outstanding (Diluted Average) stood at $279.7 million in 2022, then decreased by 14.51% to $239.1 million in 2023, then grew by 3.8% to $248.2 million in 2024, then grew by 3.32% to $256.4 million in 2025.
  • Per Business Quant, the three most recent readings for UEEC's Shares Outstanding (Diluted Average) are $256.4 million (Q3 2025), $257.1 million (Q2 2025), and $254.6 million (Q1 2025).